IL10 and neoplasm: Previously, it was shown that PSK can suppress production of IL-10, VEGF, and TGF-β1 [17]-[19], thus, DC/tumor activated with combined OK-432 and PSK may be stimulatory immunogenic due to decreased production of immune-suppressive molecules.